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Abstract: Carbon nanoparticles, with their high biocompatibility and low toxicity, have recently 
been considered for biomedical applications, including antiangiogenic therapy. Critical to normal 
development and tumor formation, angiogenesis is the process of forming capillary blood 
vessels from preexisting vessels. In the present study, we evaluated the effects of diamond and 
graphite nanoparticles on the development of chicken embryos, as well as vascularization of the 
chorioallantoic membrane and heart at the morphological and molecular level. Nanoparticles 
did not affect either body/heart weight or serum indices of the embryos’ health. However, 
vascularization of the heart and the density of branched vessels were significantly reduced after 
treatment with diamond nanoparticles and, to a lesser extent, graphite nanoparticles. Application 
of nanoparticles significantly downregulated gene and protein expression of the proangiogenic 
basic fibroblast growth factor, indicating that both diamond and graphite nanoparticles inhibit 
angiogenesis.
Keywords: diamond, graphite, nanoparticles, vasculogenesis, bFGF, VEGF
Introduction
Increasing interest in the  application of diamond nanoparticles (ND) also referred to 
as nanodiamonds in biomedicine continues due to their high biocompatibility and low 
toxicity.1,2 In vitro investigations have shown that the biocompatibility of ND is signifi-
cantly higher than other forms of carbon nanoparticles. Moreover, ND do not generate 
reactive oxygen species and have been shown to be nontoxic in neuroblastoma cells.3 
Furthermore, at concentrations ranging from 1–100 µg/mL, ND do not affect protein 
expression or morphology of epithelial and fibroblast cell lines.4 Additionally, ND do 
not initiate an inflammatory response from macrophages.5 It has also been suggested 
that ND accumulate in lung tissue and interact with cell membrane proteins, but their 
existence inside the cells does not cause pulmonary toxicity.4 In vivo studies did not 
observe any negative effects in laboratory animals. ND administered to mice over 
6 months has not been shown to have any detrimental effects on growth and develop-
ment, fertility, and immunity, as well as biochemical and morphological parameters of 
blood.1,6 Another study determined that ND had no effect on the expression of cytokine 
genes involved in cellular inflammation.2
In HL-60 cells, a human promyelocytic leukemia cell line, it has been demonstrated 
that ND are biologically active upon administration. Specifically, they can influence 
expression of genes involved in cellular and genotoxic stress, and activate oxidative 
stress defense mechanisms.7,8 Furthermore, ND regulate phagocyte activity of neutro-
phils in the inflammatory site.9 In a previous study by our research group, ND down-
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regulated expression of basic fibroblast growth factor (bFGF) 
at the messenger ribonucleic acid (mRNA) level in tumor cell 
cultures of glioblastoma multiforme cultured in ovo, leading 
to a decrease in both tumor size and mass.10 Similar antian-
giogenic activities (ie, decreasing angiogenesis induced by 
bFGF and vascular endothelial growth factor [VEGF]) were 
observed after application of graphite nanoparticles (GR), 
multiwalled carbon nanotubes, and fullerenes.11 The biologi-
cal activities of GR have not been studied in detail; however, 
graphite particles of 1 µm diameter have been shown to elicit 
an inflammatory reaction by murine macrophage cells (J 774 
cell line) that was much more intensive than after fullerenes 
and single wall nanotubes treatment. Moreover, graphite 
particles led to severe cell damage and death.12 Inflamma-
tory responses were also observed in rats after inhalation of 
graphite particles.13
Angiogenesis is the process of forming capillary blood 
vessels from preexisting vessels.14 It is required for embryonic 
development,15 wound healing, and tissue repair.16 bFGF has 
the ability to regulate the growth and function of vascular cells, 
such as endothelial and smooth muscle cells, by stimulating 
the growth and development of new blood vessels, but it is 
also a potent angiogenic molecule.17,18 VEGF is an established 
regulator of angiogenesis, and is more efficient than bFGF for 
stimulation of endothelial cell differentiation.19 Therefore, the 
antiangiogenic properties of carbon nanoparticles may be a 
double-edged sword. In tumor cells, such antiangiogenic prop-
erties are beneficial for treatment of disease; in normal cells, 
however, growth and development of the vascular system 
may be inadvertently reduced, leading to inefficient supply 
of nutrients and oxygen to normal tissue, resulting in severe 
defects and embryolethality.20,21 Furthermore, disruption of 
angiogenesis has been proposed to be a sensitive method for 
developmental toxicity evaluation of environmental chemicals 
acting as putative vascular disruptor compounds.22,23
We hypothesized that both ND and GR may reduce blood 
vessel formation and affect development of the circulatory 
system by inhibiting proangiogenic factors. The objective of 
the present study was to evaluate the effects of ND and GR on 
growth and development of chicken embryos with particular 
emphasis on the vascular system and heart vascularization 
at the morphological and molecular level.
Materials and methods
Nanoparticles
ND (explosion synthesized; specific surface area, ∼282 m2/g; 
purity, .95%) and GR (explosion synthesized; specific 
surface area, 540–650 m2/g; purity, .93%) were obtained 
from Sky Spring Nanomaterials Inc (Houston, TX, USA).
The nanoparticles were examined using a JEM-2000EX 
transmission electron microscope (TEM) at 200 kV (JEOL, 
Tokyo, Japan). Typical TEM images of nanoparticles are pre-
sented in Figure 1. ND and GR ranged in size from 1–5 nm. 
Nanoparticles were dispersed by sonification in MilliQ water 
(EMD Millipore, Billerica, MA, USA) to obtain  concentrations 
of 50, 500, or 5,000 µg/mL. Zeta potential of 50 µg/mL colloids 
was measured by the laser dynamic scattering- electrophoretic 
method with Smoluchowski approximation using a Zetasizer 
Nano ZS, model ZEN3500 (Malvern Instruments, Malvern, 
UK). Each sample was measured after 120 seconds of sta-
bilization at 25°C. Observed zeta potential for ND and GR 
was −39.3 mV and 28.7 mV, respectively.
animal models
Fertilized eggs (n = 120) from Ross Line 308 hens were 
obtained from a commercial hatchery, stored for 4 days at 
12°C, then incubated under standard conditions (37°C, 60% 
humidity, turned once per hour). Prior to incubation, the eggs 
were weighed and randomly divided into three groups, each 
with 40 eggs. Group I was the control group, treated with 
Figure 1 Transmission electron microscopy images of nanoparticles.
Note: Images of ND (A and B) and gr (C and D).
Abbreviations: ND, diamond nanoparticles; GR, graphite nanoparticles.
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phosphate buffered saline (PBS). Group II was treated with 
ND, while group III was treated with GR. Experimental solu-
tions were administered in ovo, at the beginning of incubation, 
by injection of 0.3 mL PBS containing nanoparticle colloids 
(50, 500, or 5,000 µg/mL) into the air sack using a sterile 
1 mL tuberculin syringe. Hydrocolloids of ND (50, 500, or 
5,000 µg/mL) injected into eggs were a source of carbon 
nanoparticles in a dose of on average 0.3, 3.2 and 31.8 g/kg 
body weight, respectively. Hydrocolloids of GR (50, 500 
or 5,000 µg/mL) were a source of carbon nanoparticles in a 
dose of average 0.3, 3.3 and 32.8 g/kg body weight. After 
19 days of incubation, embryos were sacrificed by decapita-
tion and weighed. The hearts were dissected, fixed in liquid 
nitrogen, and stored at −80°C until further analyses. Blood 
was taken during decapitation, and serum was collected after 
centrifugation at 3,000 rpm for 15 minutes.
angiogenesis assay
For the evaluation of vascular systems growing outside the 
embryo, eggs were divided into three groups (30 eggs in 
each), and then injected with various experimental solutions 
(PBS, ND, and GR). After 11 days of incubation, embryos 
were very gently held out on the Petri dish, and the vascular 
system was examined using an Olympus SZX10 stereoscopic 
microscope with Imaging Software Cell (Olympus Corpora-
tion, Tokyo, Japan).
Angiogenesis was evaluated using the chicken embryo 
chorioallantoic membrane (CAM) vascularization method. 
Briefly, gelatin sponges (Pfizer, Inc, New York, NY, USA) 
and Whatman filter paper rings (10 mm diameter) were 
soaked in PBS, proangiogenic factor-bFGF (positive con-
trol), and hydrocolloids of ND or GR. Gelatin sponges or 
filter papers were implanted on top of the growing CAM on 
day 8 of incubation.24 After 3 days of incubation, a 1 cm2 
window in the shell was created to remove 3 mL of  albumin. 
The window was sealed with sterile aluminum foil, and 
eggs were incubated for an additional 5 days. On day 8 of 
incubation, windows were opened and sterile gelatin sponges 
or filter paper soaked in PBS containing nanoparticle solu-
tions were placed over the developing CAM. Windows 
were again sealed, and embryos were incubated for an 
additional 3 days. On day 11 of incubation, morphology of 
blood vessels around the implant was examined using an 
Olympus SZX10 microscope with Imaging Software Cell. 
The methodology of quantifying blood vessel development 
on paper implant was the same as described before.25 Blood 
vessel length and number of branch points were calculated 
from seven chicken embryo CAM images from each group. 
Photos were analyzed with CellSens Dimension Desktop 
version 1.3 (Olympus Corporation).
Protein expression of bFgF
A heart sample was placed in chilled RIPA (Radio-
 Immunoprecipitation Assay) buffer (150 mM sodium  chloride, 
0.5% sodium deoxycholate, 1% NP-40, 0.1% sodium dodecyl 
sulfate [SDS], 50 mM tris(hydroxymethyl)aminomethane 
pH 7.4) with protease inhibitors  (Sigma-Aldrich, St Louis, 
MO, USA) in an ice bath then homogenized using a  Polytron 
PT-MR 2100 (Kinematica AG, Lucerne,  Switzerland). The 
homogenate was centrifuged, and the supernatant was col-
lected in chilled microtubes. Protein concentration was 
measured using a Total Protein Kit (Micro Lowry,  Peterson’s 
Modification, Sigma-Aldrich). bFGF protein level was 
measured using an enzyme-linked  immunosorbent assay 
(ELISA) kit for gallinaceous bFGF (Uscn Life Science Inc., 
Houston, TX, USA) according to manufacturer’s instruc-
tions. Absorbance at 450 nm was measured in an Infinite 
M200 microplate reader (Tecan Group AG, Männedorf, 
Germany).
mrNa expression of bFgF and VegF
Ribonucleic acid (RNA) was purified using the SV Total 
RNA Isolation System (Promega Corporation, Fitchburg, 
WI, USA) and quantified using a NanoDrop spectropho-
tometer (Thermo Fisher Scientific, Waltham, MA, USA). 
It was transcribed into complementary deoxyribonucleic 
acid (cDNA) using both random hexamer priming and oligo 
(dT), and the products of these reactions were mixed. The 
polymerase chain reaction (PCR) primer oligonucleotides 
(Table 1) were designed from chicken mRNA sequences for 
VEGF and bFGF, and the PCR conditions were optimized 
on chicken heart cDNA samples. The primers amplified the 
expected band on the cDNA samples from control chicken. 
Quantification of cDNA was subsequently performed by 
real-time PCR using SYBR Green I detection and the 
LightCycler System (F Hoffmann-La Roche Ltd, Basel, 
Switzerland). For each sample, 200 ng of a cDNA template 
was added to 12.5 µL of QuantiTect SYBR Green Master 
IX (Qiagen, Hilden, Germany), 0.15 µL of both forward 
and reverse primers (final concentration of 0.6 µM each), 
and RNA-free water to a final volume of 20 µL. An initial 
denaturing step at 95°C for 15 minutes was followed by 
40 cycles with a denaturing step at 94°C (15 seconds), an 
annealing step at 56°C (30 seconds), and an elongation step 
at 72°C (60 seconds). The cycling reports and melting curves 
were evaluated as part of the analysis. All reactions were 
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performed in triplicate. For all analyses, quantification was 
made relative to expression of actin beta (ACTB) and elonga-
tion factor 1 alpha 2 (EEF1A2) housekeeping genes.
Biochemical analysis
Alanine transaminase (ALT) and asparagine transaminase 
(AST) activity were measured in blood serum collected from 
embryos using dry chemistry methods that required use of 
a chemical analyzer (Vitros DT 60 II) and slide kits from 
Johnson and Johnson (New Brunswick, NJ, USA). Total 
antioxidant status (TAS) was measured in serum using a 
Randox Laboratories Ltd kit (London, UK).
statistical analysis
Data analyses were conducted in SAS26 (SAS Institute Inc, 
Cary, NC, USA) using a general linear model procedure. 
 Differences between groups were tested by least square 
means. Statistical significance was defined as P , 0.05.
Results
caM angiogenesis
Development of blood vessels after treatments with ND and 
GR was initially evaluated on chicken embryo CAM after 
11 days of incubation. In all groups, blood vessel networks 
were properly organized with a characteristic branched pat-
tern (Figure 2). However, density of vessels, especially small 
capillary vessels, growing on CAM was slightly reduced in 
treatment groups compared to the control embryos. To verify 
these observations, the experiment with implantation of gel 
sponge soaked with PBS, ND, GR, and proangiogenic factor 
(bFGF) was carried out. Evaluation of neovascularization of 
implants showed that the density of vessels branching, grow-
ing under the gel implant, was significantly reduced after ND 
treatment and, to a lesser extent, GR treatment compared to 
PBS and bFGF implants (Figure 2). A characteristic “spoked-
wheel” pattern was seen only around bFGF-soaked implants. 
Experiments with filter paper implants soaked with ND or GR 
showed similar results (Figure 2). Length of vessels treated 
with ND was decreased by 45% and for GR by 15% (mean 
length of blood vessels on 6.25 mm2: control 9516 µm; ND 
6123 µm; GR 8095 µm). The number of vessel branch points 
decreased after treatment with ND and GR by 35% and 14%, 
respectively (mean number of branch points on 6.25 mm2: 
control 11.0; ND 9.6; GR 7.2). Moreover, the implants were 
poorly furnished with CAM mesenchymal cells, and some of 
the discs soaked with ND did not adhere to CAM and were not 
A B C D
GFE
1000 um 1000 um 1000 um
1 mm2 mm2 mm 1 mm
Figure 2 caM vascularization.
Notes: Filter paper implants: (A) control group; (B) ND-treated group; and (C) gr-treated group. gelatin sponges: (D) control group; (E) positive control with bFGF; 
(F) diamond nanoparticles-treated group; and (G) gr-treated group. representative vessels of control caM (A) and after the administration of (B) ND and (C) gr.
Abbreviations: CAM, chorioallantoic membrane; ND, diamond nanoparticles; GR, graphite nanoparticles; bFGF, basic fibroblast growth factor.
Table 1 Oligonucleotide sequences used in real-time Pcr
Target  
gene
Forward primer Reverse primer Product size  
(base pairs)
Annealing  
temperature
VEGF Tga ggg ccT aga aTg TgT cc TcT TTT gac ccT Tcc ccT TT 194 62°c
bFGF ggc acT gaa aTg Tgc aac ag Tcc agg Tcc agT TTT Tgg Tc 151 62°c
EEF1A2 agc aga cTT TgT gac cTT gcc Tga caT gag aca gac ggT Tgc 85 62°c
ACTB gTc cac cTT cca gca gaT gT aTa aag cca Tgc caa TcT cg 169 60°c
Abbreviations: PCR, polymerase chain reaction; VEGF, vascular endothelial growth factor; bFGF, basic fibroblast growth factor; EEF1A2, elongation factor 1 alpha 2; ACTB, beta-actin.
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covered by cells. Furthermore, vessels infiltrating filter discs 
were absent or rarely seen. This observation was confirmed 
also on CAM vessels after injection of nanoparticles into the 
air sack (Figure 3). Nanoparticles that agglomerated were 
attached to the CAM blood vessels, suggesting that some of 
the nanoparticles reached the blood-circulating system.
Body weight and health indices
Chicken embryo development was evaluated on day 19 of 
incubation. ND and GR at 50, 500 µg/mL (data not shown) 
or 5,000 µg/mL (Table 2) were not harmful to embryos, and 
there were no differences in body and heart weights between 
the groups. Macroscopic morphological abnormalities were 
not seen.
The activities of plasma serum ALT and AST were not 
affected by nanoparticles. Similarly, the TAS was not dif-
ferent between groups (Table 2).
heart examination
Vascularization of the heart (Figure 4) in the ND and GR 
groups was less developed than in the control group.  Injection 
of ND or GR at concentrations of 50 and 500 µg/mL did 
not influence bFGF and VEGF gene expression in the heart 
(Table 3). However, 5,000 µg/mL ND or GR significantly 
decreased expression of bFGF, but not VEGF, at the mRNA 
level. The results measured with the reference gene ACTB 
were validated with the reference gene EEF1A2 and were 
in agreement with the concentrations of the bFGF protein 
(Table 2).
Discussion
A chicken embryo possesses several experimental advan-
tages as a biological model. Avian embryos develop outside 
mother organisms, and therefore exclude direct effects of 
the mother. Embryo development in the egg is sterile and 
immunologically inert.27 Furthermore, development of part 
of the vascular system outside of the embryo’s body allows 
for easier evaluation. Moreover, embryo growth is very fast. 
Cell proliferation and differentiation are extremely fast, and 
molecular reactions are prompt and potent; consequently, the 
responses to toxic factors are fast and very sensitive. Hence, 
this model is often used to investigate angiogenesis25,27,28 
and evaluate toxicity of drugs and other supplements in 
humans.29,30
Evaluation of chicken embryo morphology indicated that 
neither ND nor GR were harmful to embryos. The activities 
of ALT and AST markers of hepatic and muscle (including 
heart muscle) cell membrane integrity were also not changed. 
An increased activity of these enzymes in blood may be an 
indication that cytoplasm is leaking from cells, which may 
be a symptom of toxicity due to ND or GR. For instance, 
elevated levels of ALT were observed after treating zebrafish 
with copper nanoparticles at 1.5 µg/mL,31 mice with titanium 
dioxide and zinc nanoparticles (5 g/kg body weight),32 gold 
nanoshells (57 µg/mL).33 In the present investigation, the 
highest concentration (5,000 µg/mL) of ND and GR injected 
into eggs were a source of carbon nanoparticles in a dose 
of on average 31.8 g/kg body weight for ND and 32.8 g/kg 
for GR, which were relatively high doses. Oxidative stress 
is an important pathway of toxicity of nanomaterials and 
Figure 3 Visualization of CAM vascularization in 11-day-old chicken embryo.
Notes: experimental solutions were administered in ovo by injection of 0.3 mL PBS 
containing hydrocolloids of ND or GR (5,000 µg/mL) into the air sack. (A) control 
CAM and CAM after the administration of (B) ND or (C) gr. agglomerates of ND 
located around vessels (D).
Abbreviations: CAM, chorioallantoic membrane; PBS, phosphate buffered saline; 
ND, diamond nanoparticles; GR, graphite nanoparticles.
Table 2 Body weight, heart weight, and biochemical parameters 
of chicken embryos
Group ANOVA
Control ND GR SEM P-value
Body weight (g)a 48.3 47.2 45.8 0.708 0.4010
Heart weight (g)a 0.26 0.26 0.27 0.011 0.5810
Heart weight/100 g  
body weighta
0.53 0.55 0.59 0.016 0.4801
alT (U/l)b 13.5 18.0 12.4 0.23 0.2208
asT (U/l)b 242 268 235 12.9 0.1349
Total antioxidant  
status (mmol/l)b
1.55 1.47 1.45 0.124 0.4500
bFgF protein pg/mlc 66.1* 53.9** 57.6** 3.07 0.0143
Notes: Activity of ALT, AST, and total antioxidant status in blood serum. bFGF 
protein expression in the heart of embryos. Mean values for the control group and 
groups administered with 5,000 µg/mL hydrocolloids of ND and GR. *, ** values 
within rows with different superscripts are significantly different, P , 0.05. an = 40; 
bn = 8; cn = 5.
Abbreviations: ND, diamond nanoparticles; GR, graphite nanoparticles; 
ANOVA, analysis of variance; SEM, standard error of mean; ALT, alanine 
transaminase; AST, asparagine transaminase; bFGF, basic fibroblast growth factor.
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elevation of TAS would indicate that tested nanoparticles 
trigger a defense mechanism against free radicals. In the pres-
ent investigation, the antioxidant status measured in serum 
did not differ after treatments with ND or GR, suggesting 
that oxygen availability in the environment of the vascular 
endothelial cells was adequate and that hypoxia did not occur 
after administration of the carbon nanoparticles. Observed 
results confirm the suspected high biocompatibility of carbon 
nanoparticles, especially ND.1
A previous study by Marcon et al34 showed that 
2–200 µg/mL ND (with −OH groups on the surface) 
injected into Xenopus embryos had no significant impact 
on embryo survival. However, the frequency of abnor-
mally developed embryos increased, indicating mutagenic 
effects of ND. Contrary to Xenopus embryos, growth and 
development of chicken embryos in the present work were 
not affected by ND or GR (Table 2). Similarly, a different 
carbon nanomaterial (single wall nanotubes) did not show 
toxic side effects when used as a carrier of antiangiogenic 
drug thalidomide in the zebrafish embryos.35 Since ND was 
previously shown to decrease angiogenesis in glioblastoma 
multiforme cell cultures in ovo,10 we focused our inves-
tigation on the growth and development of the vascular 
system in embryos. Vascular development has been used 
for embryonic development toxicity evaluation for drugs 
and chemicals using high-throughput screening.22,23 In the 
present experiment, density of vessels and branching were 
reduced in treatment groups compared to control embryos. 
Implants soaked with ND were poorly furnished with CAM 
mesenchymal cells, which suggests that ND inhibited growth 
of epithelial, endothelial, and fibroblast cells, as well as their 
precursors, consequently leading to inhibition of blood vessel 
growth. ND inhibited vasculogenesis and/or angiogenesis, 
whereas GR had a tendency to reduce vessel growth.
Nanoparticles that agglomerated after injection into 
the chicken embryo air sac were attached to the CAM 
blood  vessels. This suggests that part of the nanoparticles 
reached the blood-circulating system and were transported 
within the organism. In vivo experiments have previously 
shown that ND intravenously injected into mice were retained 
in the liver, spleen, and lungs,36 and that they accumulated 
in human lung cells.4 In the current study, the heart was the 
focus of investigation since it appears very early in chicken 
embryogenesis and is in permanent contact with blood. 
Examination of the heart (Figure 4) showed that vasculariza-
tion in the ND and GR groups was less developed than in the 
control group. In light of this observation, we presumed that 
ND were able to downregulate genes responsible for migra-
tion of chorioallantoic cells, as well as differentiation and 
maturation, allowing mesenchymal cells to invade and initi-
ate angiogenesis. Chorionic and other epithelial cells highly 
express bFGF protein, especially during the early stages 
of embryogenesis,37 and also stimulate endothelial cells to 
form new vessels. Additionally, endogenous chicken bFGF, 
expressed by endothelial cells, may play a significant role in 
CAM vascularization by potentially stimulating proliferation 
of endothelial cells to promote migration, redistribution, and 
invasiveness.38 This may indicate that ND and, to a lesser 
degree GR, downregulate bFGF gene expression and in 
this way impair the environment for vessel development. 
Figure 4 Images of chicken embryo heart.
Notes: experimental solutions were administered in ovo by injection of 0.3 mL PBS containing 5,000 µg/mL hydrocolloids of nanoparticles into the air sack. (A) control 
heart and after the administration of (B) ND or (C) gr.
Abbreviations: CAM, chorioallantoic membrane; PBS, phosphate buffered saline; ND, diamond nanoparticles; GR, graphite nanoparticles.
Table 3 gene expression of bFGF and VEGF measured in 
heart tissue
Group ANOVA
Control ND GR SEM P-value
bFGF mrNa* 1.29a 0.67b 0.83a,b 0.075 0.0114
bFGF mrNa** 1.38a 0.71b 0.91a,b 0.079 0.0104
VEGF mrNa* 1.00 0.83 0.89 0.018 0.2026
VEGF mrNa** 1.06 0.99 0.99 0.009 0.7366
Notes: Mean values for the control group and groups administered 5,000 µg/ml 
hydrocolloids of ND and GR nanoparticles. a, b values within rows with different 
superscripts are significantly different, P , 0.05, n = 5. *relative expression 
normalized against ACTB; **relative expression normalized against EEF1A2.
Abbreviations: bFGF, basic fibroblast growth factor; VEGF, vascular endothelial growth 
factor; ND, diamond nanoparticles; GR, graphite nanoparticles; ANOVA, analysis of 
variance; SEM, standard error of mean; ALT, alanine transaminase; AST, asparagine 
transaminase; mRNA, messenger ribonucleic acid. 
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VEGF is another key signaling factor that promotes 
angiogenesis and vasculogenesis. ND or GR at concentra-
tions of 5,000 µg/mL decreased expression of bFGF at both 
the mRNA and protein level in the heart. This observation 
is consistent with the results from experiments with mice, 
which showed that the other form of carbon (endohedral 
fullerenes with encapsulated gadolinium) downregulates the 
expression of genes encoding the fibroblast growth factor 
family (FGF1, FGF3, and FGF6).39 Furthermore, a decrease 
in bFGF expression after treatment with carbon nanotubes, 
fullerenes, or graphite has been reported in previous  studies.11 
Observed results are also consistent with our previous study 
that showed that ND and GR cause a reduction in the concen-
tration of bFGF in glioblastoma cultures in ovo.10 The FGF 
protein is a potent angiogenic factor. It also has a pleiotropic 
effect on cellular development and differentiation, including 
neuronal differentiation, smooth muscle cell proliferation, 
myogenesis, stimulation of hematopoiesis, stem cell sur-
vival, and antiapoptotic effects.17 Experiments carried out 
in vivo have shown the key role of bFGF in embryogenesis, 
especially in mesoderm induction.40 The heart is the first 
embryonic organ to develop, arising from the splanchnic 
mesoderm. The endocardium and myocardium are created 
from delaminated epithelia. Additionally, de novo construc-
tion of blood vessels begins from splanchnic mesoderm cells, 
which after transformation become hemangioblasts – the 
precursors of blood vessels.41 bFGF promotes proliferation 
and maintenance of hematopoietic progenitors and stem 
cells.42 Thus, from the very early stages of embryogenesis, 
bFGF controls processes of blood system initiation, growth, 
and development.
ND and GR did not influence VEGF mRNA expression. 
VEGF is a multifunctional heparin-binding glycoprotein that 
primarily promotes the growth of vascular endothelial cells 
derived from arteries, veins, and the lymphatic system. This 
key prosurvival factor for endothelial cells acts via antiapop-
totic pathways and is controlled by the autocrine or paracrine 
release of several major growth factors, depending on the 
oxygen status of the microenvironment and local hypoxia.43,44 
However, embryo heart muscle may not be suitable tissue for 
VEGF measurements, and expression of this factor should 
be examined in vessels.45
Although ND and GR had no significant adverse effects 
on body weight and biochemical health indices of chicken 
embryos, results from the current study suggest that down-
regulation of bFGF by ND and GR may be a consequence of 
changes in mesoderm proliferation and inhibition of angio-
blast induction. Downregulation of bFGF can be beneficial 
in angiogenesis-dependent diseases and antitumor therapies, 
especially in case of anti-VEGF therapy resistance, charac-
teristic for many tumor types.46 However, the disruption of 
angiogenesis by antiangiogenic tumor drugs may induce 
cardiac dysfunction47 and other severe side effects.48 Conse-
quently, the antiangiogenic effects observed in the present 
CAM implantation experiments, as well as reduction of 
heart muscle vascularization, shall be considered prior to any 
therapeutic application of these nanoparticles; however, this 
has to be based on a follow-up, and more detailed research 
of other animal models.
Conclusion
Nanoparticles did not affect body weight and serum health 
indices of embryos. However, vascularization of the heart and 
the density of branched vessels were significantly reduced. 
Furthermore, high doses of ND and GR led to significant 
downregulation of bFGF expression in the heart, indicating 
that both ND and GR inhibit angiogenesis.
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